Diagnostic applications of immunohistochemistry to thyroid tumors

Acta Histochemica et Cytochemica

Volumn 32, Issue 2, 1999, Pages 165-170

  Katoh, Ryohei ^a   Kawaoi, Akira ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Histopathology; Immunohistochemistry; Intermediate filaments; Thyroid specific proteins

Indexed keywords

EID: 0033025921     PISSN: 00445991     EISSN: None     Source Type: Journal    
DOI: 10.1267/ahc.32.165     Document Type: Conference Paper

References (37)

1. Czyz, W., Joensuu, H., Pylkkanen, L. and Klemi, P. J.: p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid. J. Pathol 174; 267-274, 1994.
2. Davila, R. M., Bedrossian, C. W. M. and Silverberg, A. B.: Immunocytochemistry of the thyroid in surgical and cytologic specimens. Arch. Pathol. Lab. Med. 112; 51-56, 1988.
3. Dobashi, Y., Sakamoto, A., Sugimura, H., Mernyei, M., Mori, M., Oyama, T. and Machinami, R.: Overexpression of p53 as a possible prognostic factor in human thyroid carcinoma. Am. J. Surg. Pathol. 17; 375-381, 1993.
4. Fonseca, E., Nesland, L. M. and Sobrinho-Simoes, M.: Expression of stratified epithelial-type cytokeratins in hyalinizing trabecular adenomas supports their relationship with papillary carcinomas of the thyroid. Histopathology 31; 330-335, 1997.
5. Fonseca, E., Nesland, J. M., Höie, J. and Sobrinno-Simoes, M.: Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins. Virchows Arch. 430; 239-245, 1997.
6. Guazzi, S., Price, M., De Felice, M., Damante, G., Mattei, M. G. and Di Lauro, R.: Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J. 9; 3631-3639, 1990.
7. Hales, M., Roseriau, W., Okerlund, M. D. and Glante, M.: Carcinoma of the thyroid with a mixed medullary and follicular pattern. Cancer 30; 1352-1359.
8. Johnson, T. L., Lloyd, R. V. and Thor, A.: Expression of ras oncogene p21 antigen in normal and proliferative thyroid tissue. Am. J. Pathol. 127; 60-65, 1987.
9. Katoh, R., Suzuki, K., Miyagi, E. and Kawaoi, A.: Thyroid transcription factor-1 (TTF-1). Acta Histochem. Cytochem. 31; 287-290, 1998.
10. Katoh, R., Kawaoi, A., Miyagi, E., Li, X., Suzuki, K., Nakamura, Y. and Kakudo, K.: Gene expression and localization of thyroid transcription factor-1 (TTF-1) in human thyroid tumor tissues using a nonisotopic in situ hybridization, (in submisson)
11. Katoh, R., Bray, C. B., Suzuki, K. Komiyama, A., Hemmi, A., Kawaoi, A., Oyama, T., Sugai, T. and Sasou, S.: Growth activity in hyperplastic and neoplastic human thyroid determined by an immunohistochemical staining procedure using monoclonal antibody MIB-1. Hum. Pathol. 26; 139-146, 1995.
12. Kawaoi, A., Okano, T., Nemoto, N. and Shikata, T.: Production of thyroxine (T4) and triiodothyronine (T3) in nontoxic thyroid tumors. An immunohistochemistry. Virchows Arch. [A] 390; 249-257, 1981.
13. Kawaoi, A., Okano, T., Nemoto, N., Shiina, Y. and Shikata, T.: Simultaneous detection of thyroglobulin (Tg), thyroxine (T4), and triiodothyronine (T3) in nontoxic thyroid tumors by the immunoperoxidase method. Am. J. Pathol. 108; 39-49, 1982.
14. Kohn, L. D., Saji, M., Kosugi, M., Ban, T., Giuliani, C., Hidaka, A., Shimura, H., Shimura, Y. and Okajima, F.: Thyroid Diseases, Basic Science, Pathology, Clinical and Laboratory Diagnosis, ed. by L. Troncone, B. Shapiro, M. A. Satta and F. Monaco, CRC Press, Boca Raton, FL, 1993, pp. 59-118.
15. Ljunberg, O.: Thyroid carcinoma, Biopsy Patholgy of the Thyroid and Parathyroid, Biopsy Pathology Series 18, Chapman and Hall Medical, London, 1992.
16. Ljunberg, O., Boderson, L. and Bonderson, A.-G.: Differentiated thyroid carcinoma, intermediate type: a new tumor entity with features of follicular and parafollicular cell carcinoma. Hum. Pathol. 15; 218-228, 1984.
17. Logmans, S. C. and Jobsis, A. C.: Thyroid-associated antigens in routinely embedded carcinomas. Cancer 54; 274-279, 1984.
18. Mendelsohn, G., Wells, S. A. and Baylin, S. B.: Relationship of tissue carcinoembryonic antigen and calcitonin to tumor virulence in medullary thyroid carcinoma. Cancer 54; 657-662, 1984.
19. Mendelsohn, G., Eggleston, J. C., Weisburger, W. R., Gann, D. S. and Baylin, S. B.: Calcitonin and histaminase in C-cell hyperplasia and medullary thyroid carcinoma. Am. J. Pathol. 92; 35-52, 1978.
20. Miettinen, M., Kovatich, A. J. and Kärkkäinen, P.: Keratin subsets in papillary and follicular thyroid lesions. A paraffin section analysis with diagnostic implications. Virchows Arch. 431; 407-413, 1997.
21. Miettinen, M., Franssila, K., Lehto, V. P., Paasivuo, R. and Virtanen, I.: Expression of intermediate filament proteins in thyroid gland and thyroid tumors. Lab. Invest. 50; 262-270, 1984.
22. Mizukami, Y., Hashimoto, T., Nonomura, A., Michigishi, T., Nakamura, S., Noguchi, M. and Matsukawa, S.: Immunohistochemical demonstration of thyrotropin (TSH) receptor in normal and diseased human thyroid tissues using monoclonal antibody against recombinant human TSH-receptor proteins. J. Clin. Endocrinol. Metab. 79; 616-619, 1994.
23. Ordonez, N. G., El-Naggar, A. K., Hickey, R. C. and Samaan, N. A.: Anaplastic thyroid carcinpma. Immunohistochemical study of 32 cases. Am. J. Clin. Pathol. 96; 15-24, 1991.
24. Osborn, M. and Weber, K.: Tumor diagnosis by intermediate filament typing: a novel tool for surgical pathology. Lab. Invest. 48; 372-394, 1983.
25. Raphael, S. J., McKeown-Eyssen, G. and Asa, S. L.: High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors. Mod. Pathol. 7; 295-300, 1994.
26. Robbins, J., Rall, J. E. and Gorden, P.: On Metabolic Control and Disease, ed. by P. K. Bondy & L. E. Rosenberg, Saunders, Philadelphia, 1980, pp. 1325-1426.
27. Roth, K. A., Bensch, K. G. and Hoffman, A. R.: Characterization of opioid peptides in human thyroid medullary carcinoma. Cancer 59; 1594-1598, 1987.
28. Saito, T., Endo, T., Kawaguchi, A., Ikeda, M., Katoh, R., Kawaoi, A., Muramatsu, A. and Onaya, T.: Increased expression of the sodium/iodide symporter in papillary thyroid carcinomas. J. Clin. Invest. 101; 1296-1300, 1998.
29. Schelfhout, L. J. D. M., Van Muijen, G. N. P. and Fleuren, G. J.: Expression of keratin 19 distinguishes papillary carcinoma from follicular carcinoma and follicular thyroid adenoma. Am. J. Clin. Pathol 92; 654-658, 1989.
30. Schimke, R. N.: Genetic aspects of multiple endocrine neoplasia. Anna. Rev. Med. 35; 25-31, 1984.
31. Suzuki, K., Lavaroni, S., Mori, A., Okajima, F., Kimura, S., Katoh, R., Kawaoi, A. and Kohn, L. D.: Thyroid transcription factor 1 is calcium modulated and coordinately regulates genes involved in calcium homeostasis in C cells. Mol. Cell. Biol. 18; 7410-7422, 1998.
32. Suzuki, K., Lavaroni, S., Mori, A., Ohta, M., Saito, J., Pietrarelli, M., Singer, D., Kimura, S., Katoh, R., Kawaoi, A. and Kohn, L. D.: Autoregulation of thyroid-specific gene transcription by thyroglobulin. Proc. Natl. Acad. Sci. USA 95; 8251-8256, 1998.
33. Takeyama, H., Hosoya, T., Sakurai, K., Mori, Y., Watanabe, M., Kisaki, H. and Ohno, T.: Production of a novel monoclonal antibody, JT-95, which can detect antigen of thyroid carcinoma. Cancer Res. 56; 1817-1822, 1996.
34. Tuccari, G. and Barresi, G.: Immunohistochemical demonstration of ceruloplasmin in follicular adenomas and thyroid carcinomas. Histopathology 11; 723-731, 1987.
35. Uribe, M., Fenoglio-Preiser, C. M., Grimes, M. and Feind, C.: Medullary carcinoma of the thyroid gland. Clinical, pathological and immunohistochemical features with review of the literature. Am. J. Surg. Pathol. 9; 577-594, 1985.
36. Wolfe, H. J. and Delellis, R. A.: Familial medullary thyroid carcinoma and C cell hyperplasia. Clin. Endocrinol. Metab. 10; 351-365, 1981.
37. Yamashita, S., Ong, J., Fagin, J. A. and Melmed, S.: Expression of the myc cellular proto-oncogene in human thyroid tissue. J. Clin. Endocrinol. Metab. 63; 1170-1173, 1986.